Integrated Biosciences develops small-molecule medicines for age-related diseases. Its discovery platform combines biological aging datasets, optogenetic control of cellular pathways, chemistry and AI models with experimental screening to find and optimize drug candidates. Its pipeline targets age-related biology, including cardiometabolic disease.